Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JDS Pharmaceuticals
New York, New York, United Statesreuters.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
JDS successfully marketed two branded prescription psychiatry products—Lithobid® and Pexeva®. Lithobid® was the only branded sustained-release lithium carbonate product in the U.S., indicated for maintenance of bipolar disorder. Pexeva® is a branded paroxetine mesylate product indicated for several psychiatric disorders. The company advanced a once-daily lithium formulation ("Lithium QD") to Phase 3 trials and developed Mesafem™, a low-dose paroxetine capsule targeting menopausal vasomotor symptoms that was expected to enter Phase 3 at time of acquisition by Noven.
- Therapeutic areas
- Women's HealthPsychiatry
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
No major external pharma partnerships disclosed pre-acquisition. Post-acquisition activities integrated into Noven's network.
Beyond the preview
Go deeper on JDS Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JDS Pharmaceuticals.